CLINICAL_TRIALS
trial_result
· 2022-10-18
Clinical Trial Update: A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN [Phase 2]
Summary
A Phase 2b randomized, placebo-controlled trial evaluating an RSV vaccine in pregnant women has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Respiratory Tract Infection | Phase 2 | Status: COMPLETED | Results posted: 2022-10-18